These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 30107391

  • 1. Y-27632 preconditioning enhances transplantation of human-induced pluripotent stem cell-derived cardiomyocytes in myocardial infarction mice.
    Zhao M, Fan C, Ernst PJ, Tang Y, Zhu H, Mattapally S, Oduk Y, Borovjagin AV, Zhou L, Zhang J, Zhu W.
    Cardiovasc Res; 2019 Feb 01; 115(2):343-356. PubMed ID: 30107391
    [Abstract] [Full Text] [Related]

  • 2. N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.
    Lou X, Zhao M, Fan C, Fast VG, Valarmathi MT, Zhu W, Zhang J.
    Cardiovasc Res; 2020 Mar 01; 116(3):671-685. PubMed ID: 31350544
    [Abstract] [Full Text] [Related]

  • 3. Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity.
    Zhao M, Tang Y, Ernst PJ, Kahn-Krell A, Fan C, Pretorius D, Zhu H, Lou X, Zhou L, Zhang J, Zhu W.
    J Vis Exp; 2019 Jul 10; (149):. PubMed ID: 31355804
    [Abstract] [Full Text] [Related]

  • 4. CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice.
    Fan C, Tang Y, Zhao M, Lou X, Pretorius D, Menasche P, Zhu W, Zhang J.
    J Mol Cell Cardiol; 2020 Apr 10; 141():1-10. PubMed ID: 32169551
    [Abstract] [Full Text] [Related]

  • 5. Angiopoietin-1 enhanced myocyte mitosis, engraftment, and the reparability of hiPSC-CMs for treatment of myocardial infarction.
    Tao Z, Loo S, Su L, Tan S, Tee G, Gan SU, Zhang J, Chen X, Ye L.
    Cardiovasc Res; 2021 May 25; 117(6):1578-1591. PubMed ID: 32666104
    [Abstract] [Full Text] [Related]

  • 6. Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction.
    Tan SH, Loo SJ, Gao Y, Tao ZH, Su LP, Wang CX, Zhang SL, Mu YH, Cui YH, Abdurrachim D, Wang WH, Lalic J, Lim KC, Bu J, Tan RS, Lee TH, Zhang J, Ye L.
    Theranostics; 2021 May 25; 11(16):7879-7895. PubMed ID: 34335970
    [Abstract] [Full Text] [Related]

  • 7. Rho-associated kinase inhibitors promote the cardiac differentiation of embryonic and induced pluripotent stem cells.
    Cheng YT, Yeih DF, Liang SM, Chien CY, Yu YL, Ko BS, Jan YJ, Kuo CC, Sung LY, Shyue SK, Chen MF, Yet SF, Wu KK, Liou JY.
    Int J Cardiol; 2015 Dec 15; 201():441-8. PubMed ID: 26313863
    [Abstract] [Full Text] [Related]

  • 8. Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell-Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine.
    Gao L, Gregorich ZR, Zhu W, Mattapally S, Oduk Y, Lou X, Kannappan R, Borovjagin AV, Walcott GP, Pollard AE, Fast VG, Hu X, Lloyd SG, Ge Y, Zhang J.
    Circulation; 2018 Apr 17; 137(16):1712-1730. PubMed ID: 29233823
    [Abstract] [Full Text] [Related]

  • 9. Spheroids of cardiomyocytes derived from human-induced pluripotent stem cells improve recovery from myocardial injury in mice.
    Mattapally S, Zhu W, Fast VG, Gao L, Worley C, Kannappan R, Borovjagin AV, Zhang J.
    Am J Physiol Heart Circ Physiol; 2018 Aug 01; 315(2):H327-H339. PubMed ID: 29631371
    [Abstract] [Full Text] [Related]

  • 10. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.
    Zhu W, Zhao M, Mattapally S, Chen S, Zhang J.
    Circ Res; 2018 Jan 05; 122(1):88-96. PubMed ID: 29018036
    [Abstract] [Full Text] [Related]

  • 11. Combined Treatment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates.
    Cheng YC, Hsieh ML, Lin CJ, Chang CMC, Huang CY, Puntney R, Wu Moy A, Ting CY, Herr Chan DZ, Nicholson MW, Lin PJ, Chen HC, Kim GC, Zhang J, Coonen J, Basu P, Simmons HA, Liu YW, Hacker TA, Kamp TJ, Hsieh PCH.
    Circulation; 2023 Oct 31; 148(18):1395-1409. PubMed ID: 37732466
    [Abstract] [Full Text] [Related]

  • 12. Expandable human cardiovascular progenitors from stem cells for regenerating mouse heart after myocardial infarction.
    Schwach V, Gomes Fernandes M, Maas S, Gerhardt S, Tsonaka R, van der Weerd L, Passier R, Mummery CL, Birket MJ, Salvatori DCF.
    Cardiovasc Res; 2020 Mar 01; 116(3):545-553. PubMed ID: 31287499
    [Abstract] [Full Text] [Related]

  • 13. Electrical Stimulation Enhances Cardiac Differentiation of Human Induced Pluripotent Stem Cells for Myocardial Infarction Therapy.
    Ma R, Liang J, Huang W, Guo L, Cai W, Wang L, Paul C, Yang HT, Kim HW, Wang Y.
    Antioxid Redox Signal; 2018 Feb 10; 28(5):371-384. PubMed ID: 27903111
    [Abstract] [Full Text] [Related]

  • 14. Cardiomyocytes from CCND2-overexpressing human induced-pluripotent stem cells repopulate the myocardial scar in mice: A 6-month study.
    Fan C, Fast VG, Tang Y, Zhao M, Turner JF, Krishnamurthy P, Rogers JM, Valarmathi MT, Yang J, Zhu W, Zhang J.
    J Mol Cell Cardiol; 2019 Dec 10; 137():25-33. PubMed ID: 31629738
    [Abstract] [Full Text] [Related]

  • 15. Metformin Preconditioning of Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells Promotes Their Engraftment and Improves Post-Stroke Regeneration and Recovery.
    Ould-Brahim F, Sarma SN, Syal C, Lu KJ, Seegobin M, Carter A, Jeffers MS, Doré C, Stanford WL, Corbett D, Wang J.
    Stem Cells Dev; 2018 Aug 15; 27(16):1085-1096. PubMed ID: 29893190
    [Abstract] [Full Text] [Related]

  • 16. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.
    Citro L, Naidu S, Hassan F, Kuppusamy ML, Kuppusamy P, Angelos MG, Khan M.
    PLoS One; 2014 Aug 15; 9(12):e116281. PubMed ID: 25551230
    [Abstract] [Full Text] [Related]

  • 17. Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction.
    Sun SJ, Lai WH, Jiang Y, Zhen Z, Wei R, Lian Q, Liao SY, Tse HF.
    Theranostics; 2021 Aug 15; 11(4):1641-1654. PubMed ID: 33408772
    [Abstract] [Full Text] [Related]

  • 18. Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
    Kobayashi H, Tohyama S, Ichimura H, Ohashi N, Chino S, Soma Y, Tani H, Tanaka Y, Yang X, Shiba N, Kadota S, Haga K, Moriwaki T, Morita-Umei Y, Umei TC, Sekine O, Kishino Y, Kanazawa H, Kawagishi H, Yamada M, Narita K, Naito T, Seto T, Kuwahara K, Shiba Y, Fukuda K.
    Circulation; 2024 Aug 20; 150(8):611-621. PubMed ID: 38666382
    [Abstract] [Full Text] [Related]

  • 19. Magnesium lithospermate B enhances the potential of human-induced pluripotent stem cell-derived cardiomyocytes for myocardial repair.
    Fan C, Qin K, Iroegbu CD, Xiang K, Gong Y, Guan Q, Wang W, Peng J, Guo J, Wu X, Yang J.
    Chin Med J (Engl); 2024 Aug 05; 137(15):1857-1869. PubMed ID: 38221772
    [Abstract] [Full Text] [Related]

  • 20. Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.
    Wendel JS, Ye L, Tao R, Zhang J, Zhang J, Kamp TJ, Tranquillo RT.
    Stem Cells Transl Med; 2015 Nov 05; 4(11):1324-32. PubMed ID: 26371342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.